Norvic Hospital IPO Expected at Rs 990 Per Share with 50% Dividend Projection Next Year

20th April 2026, Kathmandu

In a major development for Nepal’s healthcare and capital markets, Norvic International Hospital and Medical College Limited is preparing to issue its Initial Public Offering through the sophisticated book-building method.

Norvic Hospital IPO

This move positions Norvic as one of the most anticipated listings in the country, with an estimated share price expected to be around 990 per unit for general investors. As part of the rigorous preparation process, the company has announced plans to conduct a high-level roadshow on Baisakh 11, designed to engage qualified institutional investors before the final pricing is determined by the market.

The hospital’s total issued capital currently stands at 1.02 billion, and the management plans to issue 20 percent of this capital to the public. This translates to approximately 2,041,200 total shares. Under the book-building regulations, 40 percent of the issue, or 816,480 shares, is reserved for Qualified Institutional Investors, while the remaining 60 percent, totaling 1,224,720 shares, will be available for the general public.

While the estimated base price for institutions is 1,100, the general public is expected to receive a 10 percent discount, bringing their entry price to approximately 990. However, the final pricing will only be confirmed after the institutional bidding process and regulatory valuations are completed.

One of the primary factors driving investor interest is Norvic’s consistent and impressive financial performance. The hospital has shown significant profit growth over the last few years, recording a net profit of 16.71 crore in FY 2080/81, which rose sharply to 27.40 crore in FY 2081/82. By the middle of FY 2082/83, the company had already achieved a net profit of 26.90 crore, signaling a very strong upward trajectory. Looking ahead, the hospital projects its profits to reach 46.95 crore by the end of this fiscal year, with further growth anticipated to hit 73.16 crore by FY 2084/85.

The outlook for earnings per share and net worth is equally robust. Norvic projects a strong EPS of 57.51 for FY 2082/83, maintaining high levels above 55 in the subsequent years. Furthermore, the net worth per share, including revaluation, is expected to climb from 468.07 to over 600 by FY 2084/85.

Advertisement

This financial strength is the foundation for an incredibly aggressive dividend policy. The hospital has projected dividend payouts starting at 50 percent for FY 2083/84 and scaling up to a staggering 105 percent to 120 percent in the later years. This long-term projection reflects the company’s confidence in its operational efficiency and market leadership.

Founded in 1993, Norvic has evolved from a modest 30-bed center into one of Nepal’s premier private healthcare institutions. Its journey is marked by several milestones, including being the first to receive ISO 9001:2000 certification in Nepal and introducing advanced services like MRI, CT scans, and kidney transplants.

The hospital also played a critical role during the COVID-19 pandemic, dedicating 90 percent of its capacity to emergency treatment. Today, under the leadership of Chairman Rajendra Bahadur Singh and major stakeholders like Megha Chaudhary and Basant Chaudhary, the hospital is expanding into medical education and advanced diagnostic systems.

For investors, the Norvic International Hospital IPO represents an opportunity to own a stake in a high-growth, essential service industry. The healthcare sector often provides a hedge against economic volatility, and Norvic’s combination of historical success and future expansion plans makes it a unique asset. As the roadshow approaches on Baisakh 11, the focus will be on how institutional investors value the brand and its future earnings potential.

In conclusion, the upcoming IPO of Norvic International Hospital is set to redefine healthcare investment in Nepal. With a strong balance sheet, a clear roadmap for profit growth, and a commitment to rewarding shareholders with high dividends, it is a project that commands attention.

Whether you are a long-term investor looking for stability or a growth-oriented buyer, Norvic provides a compelling case for inclusion in a diversified portfolio. As the healthcare landscape in Nepal continues to modernize, Norvic remains at the forefront, bridging the gap between world-class medical services and sustainable financial success. Stay tuned for further updates as the bidding process begins and the final public price is announced.

For More: Norvic Hospital IPO